XML 36 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Corrections to Previously Issued Consolidated Financial Statements (Details) - USD ($)
2 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Sep. 30, 2016
Jul. 21, 2015
Consolidated Balance Sheet              
Prepayment $ 3,815          
Due to related party 22,517 $ 953,000   $ 953,000   6,500,000  
Total Liabilities 369,103 1,056,130   1,056,130   6,556,470  
Additional paid-in capital 1,132,685 10,586,464   10,586,464   4,733,461  
Accumulated deficit (315,602) (11,848,288)   (11,848,288)   (11,323,401)  
Total equity (deficit) 633,357 (1,048,077)   (1,048,077)   (6,379,118) $ 897,001
Consolidated Statements of Operations and Comprehensive Loss              
Selling, general and administrative expenses 315,602 169,427 $ 289,098 562,930 $ 349,486 997,263  
Research and development expenses 17,500 67,848 10,000,000 10,000,000  
Net loss from operations (315,602) (99,479) (289,098) (476,706) (10,349,518) (10,997,295)  
Loss from continuing operations before income taxes (315,602) (127,879) (292,401) (524,057) (10,352,769) (11,006,963)  
Net Loss $ (315,602) $ (127,879) $ (293,237) $ (524,887) $ (10,353,605) $ (11,007,799)  
Basic and diluted loss per share $ 0.00 $ (0.00) $ (0.00) $ (0.00) $ (0.05) $ (0.06)  
Consolidated Statements of Cash Flow              
Net loss from continuing operations $ (315,602) $ (127,879) $ (293,237) $ (524,887) $ (10,353,605) $ (11,007,799)  
Issuance of common stocks for compensation           397,960  
(Increase) decreases in prepayment (3,815)     3,815 3,815  
(Increase) decrease in due from related party            
(Decrease) increase in due to related party 22,517     (647,000) 6,477,483 6,477,483  
Increase (decrease) in due to shareholder 46,586     (46,586) (46,586)  
Net cash used in operating activities (715)     (1,115,484) (3,263,340) (3,474,707)  
Proceeds from subscription receivable     350,000 350,000  
Proceeds from issuance of common stock 948,959       2,350,000  
Net cash used in operating activities 995,545     $ 950,000 2,353,414 2,653,414  
Previously Reported [Member]              
Consolidated Balance Sheet              
Prepayment     3,500,000   3,500,000    
Due to related party        
Total Liabilities           56,470  
Additional paid-in capital           4,733,401  
Accumulated deficit     (669,207)   (669,207) (4,823,401)  
Total equity (deficit)           120,882  
Consolidated Statements of Operations and Comprehensive Loss              
Selling, general and administrative expenses           4,497,263  
Research and development expenses          
Net loss from operations           (4,497,295)  
Loss from continuing operations before income taxes           (4,506,963)  
Net Loss         $ (352,796) $ (4,507,799)  
Basic and diluted loss per share         $ 0.00 $ 0.00  
Consolidated Statements of Cash Flow              
Net loss from continuing operations         $ (352,796) $ (4,507,799)  
Issuance of common stocks for compensation         1,295,324  
(Increase) decreases in prepayment         (3,496,185)    
(Increase) decrease in due from related party         350,000    
(Decrease) increase in due to related party         (22,517) (22,517)  
Increase (decrease) in due to shareholder         (46,586)    
Net cash used in operating activities (517)       (3,857,447)    
Proceeds from issuance of common stock         897,521    
Net cash used in operating activities         2,947,521    
Restated [Member]              
Consolidated Balance Sheet              
Prepayment          
Due to related party     6,500,000   6,500,000 6,500,000  
Total Liabilities           6,556,470  
Additional paid-in capital           4,733,461  
Accumulated deficit     (10,669,207)   (10,669,207) (11,323,401)  
Total equity (deficit)           (6,379,118)  
Consolidated Statements of Operations and Comprehensive Loss              
Selling, general and administrative expenses           997,263  
Research and development expenses         10,000,000 10,000,000  
Net loss from operations           (10,997,295)  
Loss from continuing operations before income taxes           (11,006,963)  
Net Loss         $ (10,352,796) $ (11,007,799)  
Basic and diluted loss per share         $ (0.05) $ (0.06)  
Consolidated Statements of Cash Flow              
Net loss from continuing operations         $ (10,352,796) $ (11,007,799)  
Issuance of common stocks for compensation         897,521 1,295,324  
(Increase) decreases in prepayment         3,815    
(Increase) decrease in due from related party            
(Decrease) increase in due to related party         6,477,483 6,477,483  
Increase (decrease) in due to shareholder            
Net cash used in operating activities (715)       (3,263,340)    
Proceeds from subscription receivable         350,000    
Proceeds from issuance of common stock            
Net cash used in operating activities         (2,353,414)    
Adjustments No.1 [Member]              
Consolidated Balance Sheet              
Prepayment     (3,500,000)   (3,500,000)    
Due to related party     6,500,000   6,500,000 6,500,000  
Total Liabilities           6,500,000  
Additional paid-in capital            
Accumulated deficit     $ (10,000,000)   (10,000,000) (6,500,000)  
Total equity (deficit)           (6,500,000)  
Consolidated Statements of Operations and Comprehensive Loss              
Selling, general and administrative expenses           (3,500,060)  
Research and development expenses         10,000,000 10,000,000  
Net loss from operations           (6,499,940)  
Loss from continuing operations before income taxes           (6,499,940)  
Net Loss         $ (10,000,000) $ (6,499,940)  
Basic and diluted loss per share         $ (0.05) $ (0.06)  
Consolidated Statements of Cash Flow              
Net loss from continuing operations         $ (10,000,000) $ (6,499,940)  
Issuance of common stocks for compensation         897,521 (60)  
(Increase) decreases in prepayment         3,500,000    
(Increase) decrease in due from related party         (350,000)    
(Decrease) increase in due to related party         6,500,000 6,500,000  
Increase (decrease) in due to shareholder         46,586    
Net cash used in operating activities       594,107    
Proceeds from subscription receivable         350,000    
Proceeds from issuance of common stock         (897,521)    
Net cash used in operating activities         $ (594,107)    
Adjustments No.2 [Member]              
Consolidated Balance Sheet              
Due to related party            
Total Liabilities            
Additional paid-in capital           60  
Accumulated deficit            
Total equity (deficit)            
Consolidated Statements of Operations and Comprehensive Loss              
Selling, general and administrative expenses           60  
Research and development expenses            
Net loss from operations           (60)  
Loss from continuing operations before income taxes           (60)  
Net Loss           $ (60)  
Basic and diluted loss per share           $ 0.00  
Consolidated Statements of Cash Flow              
Net loss from continuing operations           $ (60)  
Issuance of common stocks for compensation           60  
(Decrease) increase in due to related party            
Net cash used in operating activities $ (198)